Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma

NCT00286013 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00286013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2004
Completion date
July 22, 2008
Enrollment
24 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced and unresectable, but non-metastatic pancreatic adenocarcinoma or cholangiocarcinoma